Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

A randomized treatment study comparing carotid stent and endarterectomy versus medical management.

Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1:1 ratio to endarterectomy versus no endarterectomy and another will randomize patients in a 1:1 ratio to carotid stenting with embolic protection versus no stenting. Medical management will be uniform for all randomized treatment groups and will be centrally directed.

Check your eligibility (clinicaltrials.gov)
Participate in a Clinical Trial at Saint John’s Cancer Institute.

Questions regarding this trial: 310-303-5515